Compare PBR & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBR | MDT |
|---|---|---|
| Founded | 1953 | 1949 |
| Country | Brazil | Ireland |
| Employees | 41778 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.4B | 131.9B |
| IPO Year | N/A | 2014 |
| Metric | PBR | MDT |
|---|---|---|
| Price | $19.99 | $86.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 19 |
| Target Price | $15.75 | ★ $109.82 |
| AVG Volume (30 Days) | ★ 34.6M | 7.3M |
| Earning Date | 05-12-2026 | 05-20-2026 |
| Dividend Yield | ★ 5.20% | 3.28% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $33,537,000,000.00 |
| Revenue This Year | N/A | $8.91 |
| Revenue Next Year | $5.33 | $6.71 |
| P/E Ratio | ★ $13.55 | $31.32 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $11.03 | $79.55 |
| 52 Week High | $21.40 | $106.33 |
| Indicator | PBR | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 63.11 | 33.23 |
| Support Level | $11.74 | $85.60 |
| Resistance Level | N/A | $88.77 |
| Average True Range (ATR) | 0.65 | 1.53 |
| MACD | -0.03 | 0.22 |
| Stochastic Oscillator | 48.95 | 29.47 |
Petrobras is a Brazil-based integrated energy company controlled by the Brazilian government. The company focuses on exploration and production of oil and gas in Brazilian offshore fields. Production in 2024 was 2.7 million barrels of oil equivalent a day (80% oil production), and reserves stood at 11.4 billion boe (85% oil). At end-2024, Petrobras operated 10 refineries in Brazil with capacity of 1.8 million barrels a day and distributes refined products and natural gas throughout Brazil.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.